Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Inclusion Criteria Patients with rheumatoid arthritis (RA) who fulfill all of the following~1. Patients who are refractory to the treatment.~2. Patients who have never been treated with Enbrel and in whom its long-term therapy may be instituted.~3. Patients without a history of or concurrent malignant tumors.~Exclusion Criteria:

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).